Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Rooney

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|February 15, 1993
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trialJ F Rooney, S E Straus, M L Mannix, et al.
The Journal of Infectious Diseases|September 1, 1992
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovirJ F Rooney, S E Straus, M L Mannix, et al.
Lancet (London, England)|December 7, 1991
Prevention of ultraviolet-light-induced herpes labialis by sunscreenJ F Rooney, Y Bryson, M L Mannix, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1987
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificityM N Ellis, P M Keller, J A Fyfe, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adultsS G Deeks, P Barditch-Crovo, P S Lietman, et al.
AIDS Research and Human Retroviruses|March 1, 1993
Cutaneous disorders and viral gene expression in HIV-1 transgenic miceJ B Kopp, J F Rooney, C Wohlenberg, et al.
Sexually Transmitted Diseases|April 1, 1989
Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpesS E Straus, M Seidlin, H E Takiff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2001
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infectionR Snoeck, M Bossens, D Parent, et al.
Antiviral Research|May 1, 1986
Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpesS E Straus, M Seidlin, H E Takiff, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1997
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV diseaseD H Shepp, C Ramirez-Ronda, L Dall, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|February 15, 1993
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trialJ F Rooney, S E Straus, M L Mannix, et al.
The Journal of Infectious Diseases|September 1, 1992
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovirJ F Rooney, S E Straus, M L Mannix, et al.
Lancet (London, England)|December 7, 1991
Prevention of ultraviolet-light-induced herpes labialis by sunscreenJ F Rooney, Y Bryson, M L Mannix, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1987
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificityM N Ellis, P M Keller, J A Fyfe, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adultsS G Deeks, P Barditch-Crovo, P S Lietman, et al.
AIDS Research and Human Retroviruses|March 1, 1993
Cutaneous disorders and viral gene expression in HIV-1 transgenic miceJ B Kopp, J F Rooney, C Wohlenberg, et al.
Sexually Transmitted Diseases|April 1, 1989
Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpesS E Straus, M Seidlin, H E Takiff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2001
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infectionR Snoeck, M Bossens, D Parent, et al.
Antiviral Research|May 1, 1986
Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpesS E Straus, M Seidlin, H E Takiff, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1997
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV diseaseD H Shepp, C Ramirez-Ronda, L Dall, et al.
Pageof 4